Mir-29b, which is regulated by the NF-κB/YY1 pathway and whose abnormal expression may contribute to myogenesis and rhabdomyosarcoma, acts as a tumor suppressor by downregulating the transcription factor Yin Yang 1 (YY1) [126]. The gene discussed is NFKB1; the disease is neoplasm.